Ian Breakspear
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ian Breakspear has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Matthew J. Leach
Joanna Briggs Institute (JBI), University of Adelaide, Adelaide 5005, Australia
2 shared publications Tobey-Ann Pinder
Vice-President, Naturopaths and Herbalists Association of Australia
2 shared publicationsAmie Steel
Deputy Chair, Australian Register of Naturopaths and Herbalists
1 shared publication- Amie Steel
National Centre for Naturopathic Medicine, Southern Cross University, Lismore, Australia
1 shared publication Andrea Bugarcic
National Centre for Naturopathic Medicine, Southern Cross University, Lismore, Australia
1 shared publicationAnne-Louise Carlton
National Centre for Naturopathic Medicine, Southern Cross University, Lismore, Australia
1 shared publication
Latest Publications
- Open Access
- 7 May 2026
- Published by Elsevier in Advances in Integrative Medicine
- Vol. 13 (2)
The role of herbal medicine in supporting cognitive dysfunction associated with long COVID: Review
- 7 May 2026
- Published by Elsevier in Advances in Integrative Medicine
- Vol. 13 (2)
Open AccessThe role of herbal medicine in supporting cognitive dysfunction associated with long COVID: Review
- Open Access
- 13 January 2025
- Published by Elsevier in Complementary Therapies in Clinical Practice
- Vol. 59, 101949
Efficacy and safety of olive leaf extract (Olea europaea L.) for glycaemic control in adults with type 2 diabetes mellitus (ESOLED): A pilot randomised controlled trial
- 13 January 2025
- Published by Elsevier in Complementary Therapies in Clinical Practice
- Vol. 59, 101949
Open AccessEfficacy and safety of olive leaf extract (Olea europaea L.) for glycaemic control in adults with type 2 diabetes mellitus (ESOLED): A pilot randomised controlled trial
- 1 July 2023
- Published by SAGE Publications in Journal of Integrative and Complementary Medicine
- Vol. 29 (6-7) , 348-360
Exploring Criteria for the Translation of Traditional Knowledge Within Contemporary Clinical Practice, Research, Policy, and Education: A Stakeholder Forum
Background: The 2018 Declaration of Astana identifies traditional knowledge (TK) as one of the drivers for strengthening primary health care systems through the use of technology (traditional medicines) and knowledge and capacity building (traditional practitioners). While TK underpins both traditional practice and the use of traditional medicines, facilitating the use of TK in contemporary health care systems has been difficult to achieve. The aim of this study was to identify key factors related to the translation of TK into contemporary settings to help establish tools to support the knowledge translation process. Methods: This study used World Café methodology to collect the observations, ideas, and perspectives of experts who use TK in their practice. These experts (n = 9) were from a variety of contexts, including clinical practice, research, education, policy, and consumer advocacy, participated in the 1-day event. Data were collected into NVivo 12 software and analyzed using inductive-deductive thematic analysis. Results: Thematic analysis identified five themes: the need to define the elements required for critical evaluation of sources of TK as evidence, the importance of applying a tradition-centric lens when translating TK for contemporary use, the need to bridge gaps between TK and its contemporary applications, the value of critically evaluating the TK translation process itself, and the recognition of traditions as living systems. Taken together, the themes showed holistic interpretation of the translation process that incorporates critical analysis of the TK itself and accountable, transparent, and ethical processes of translation that consider safety, socioeconomical and intellectual property impacts of TK in contemporary use. Conclusions: Stakeholders identified TK as a valid and important source of evidence that should guide practice in a range of contemporary settings (e.g., policy and clinical practice), and outlined important consideration for critiquing, evaluating, communicating, and using TK within these settings.
- 1 July 2023
- Published by SAGE Publications in Journal of Integrative and Complementary Medicine
- Vol. 29 (6-7) , 348-360
Exploring Criteria for the Translation of Traditional Knowledge Within Contemporary Clinical Practice, Research, Policy, and Education: A Stakeholder Forum
Background: The 2018 Declaration of Astana identifies traditional knowledge (TK) as one of the drivers for strengthening primary health care systems through the use of technology (traditional medicines) and knowledge and capacity building (traditional practitioners). While TK underpins both traditional practice and the use of traditional medicines, facilitating the use of TK in contemporary health care systems has been difficult to achieve. The aim of this study was to identify key factors related to the translation of TK into contemporary settings to help establish tools to support the knowledge translation process. Methods: This study used World Café methodology to collect the observations, ideas, and perspectives of experts who use TK in their practice. These experts (n = 9) were from a variety of contexts, including clinical practice, research, education, policy, and consumer advocacy, participated in the 1-day event. Data were collected into NVivo 12 software and analyzed using inductive-deductive thematic analysis. Results: Thematic analysis identified five themes: the need to define the elements required for critical evaluation of sources of TK as evidence, the importance of applying a tradition-centric lens when translating TK for contemporary use, the need to bridge gaps between TK and its contemporary applications, the value of critically evaluating the TK translation process itself, and the recognition of traditions as living systems. Taken together, the themes showed holistic interpretation of the translation process that incorporates critical analysis of the TK itself and accountable, transparent, and ethical processes of translation that consider safety, socioeconomical and intellectual property impacts of TK in contemporary use. Conclusions: Stakeholders identified TK as a valid and important source of evidence that should guide practice in a range of contemporary settings (e.g., policy and clinical practice), and outlined important consideration for critiquing, evaluating, communicating, and using TK within these settings.
- Open Access
- 1 December 2021
- Published by Elsevier in Integrative Medicine Research
- Vol. 10 (4) , 100747
Essential oils for agitation in dementia [rELOAD]: A pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial
- 1 December 2021
- Published by Elsevier in Integrative Medicine Research
- Vol. 10 (4) , 100747
Open AccessEssential oils for agitation in dementia [rELOAD]: A pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial
- Open Access
A Quantitative Phytochemical Comparison of Olive Leaf Extracts on the Australian Market
Olive leaf extract (OLE), prepared from the fresh or dried leaves of Olea europaea L., is generating interest as a cardiovascular and metabolic disease risk modifier. Positive effects for the leaf extract and its key phytochemical constituents have been reported on blood pressure, respiratory infections, inflammation, and insulin resistance. A variety of OLE products are available both over-the-counter and for professional dispensing. The aim of this research was to quantitatively explore the phytochemical profile of different OLE products on the Australian market. Ten OLE products available on the Australian market (five over-the-counter products and five products for professional compounding and dispensing) were quantitatively analyzed for oleuropein, hydroxytyrosol, oleacein, oleocanthal, total biophenols, maslinic acid, and oleanolic acid, using high-performance liquid chromatography (HPLC). Substantial variation in oleuropein and hydroxytyrosol levels was noted between extracts, with a trend towards higher oleuropein and lower hydroxytyrosol levels being noted in products produced using the fresh olive leaf as opposed to dry olive leaf. These results suggest that OLE products on the Australian market vary substantially in their phytochemical profiles. Products for professional compounding and dispensing in many cases contained less oleuropein than over-the-counter products, but more hydroxytyrosol and comparable total biophenol levels.
Open AccessA Quantitative Phytochemical Comparison of Olive Leaf Extracts on the Australian Market
Olive leaf extract (OLE), prepared from the fresh or dried leaves of Olea europaea L., is generating interest as a cardiovascular and metabolic disease risk modifier. Positive effects for the leaf extract and its key phytochemical constituents have been reported on blood pressure, respiratory infections, inflammation, and insulin resistance. A variety of OLE products are available both over-the-counter and for professional dispensing. The aim of this research was to quantitatively explore the phytochemical profile of different OLE products on the Australian market. Ten OLE products available on the Australian market (five over-the-counter products and five products for professional compounding and dispensing) were quantitatively analyzed for oleuropein, hydroxytyrosol, oleacein, oleocanthal, total biophenols, maslinic acid, and oleanolic acid, using high-performance liquid chromatography (HPLC). Substantial variation in oleuropein and hydroxytyrosol levels was noted between extracts, with a trend towards higher oleuropein and lower hydroxytyrosol levels being noted in products produced using the fresh olive leaf as opposed to dry olive leaf. These results suggest that OLE products on the Australian market vary substantially in their phytochemical profiles. Products for professional compounding and dispensing in many cases contained less oleuropein than over-the-counter products, but more hydroxytyrosol and comparable total biophenol levels.
- Open Access
- 1 April 2020
- Published by Elsevier in Fitoterapia
- Vol. 142, 104519
A systematic review and quality assessment of case reports of adverse events for borage (Borago officinalis), coltsfoot (Tussilago farfara) and comfrey (Symphytum officinale)
- 1 April 2020
- Published by Elsevier in Fitoterapia
- Vol. 142, 104519
Open AccessA systematic review and quality assessment of case reports of adverse events for borage (Borago officinalis), coltsfoot (Tussilago farfara) and comfrey (Symphytum officinale)
- 11 December 2019
- Published by Cambridge Media in Australian Journal of Herbal and Naturopathic Medicine
- Vol. 31 (4)
Formation of the Australian Naturopathic Council (ANC): formalising a new era of unity for Australian naturopathy
The Australian Journal of Herbal and Naturopathic Medicine (AJHNM) is Australia's leading herbal publication. A thoroughly modern, peer reviewed and clinically relevant journal, the AJHNM can trace its origins back to publications issued by the Association as long ago as the 1930s. Issued quarterly, the AJHNM publishes material on all aspects of herbal medicine including philosophy, phytochemistry, pharmacology and the clinical application of medicinal plants.
- 11 December 2019
- Published by Cambridge Media in Australian Journal of Herbal and Naturopathic Medicine
- Vol. 31 (4)
Formation of the Australian Naturopathic Council (ANC): formalising a new era of unity for Australian naturopathy
The Australian Journal of Herbal and Naturopathic Medicine (AJHNM) is Australia's leading herbal publication. A thoroughly modern, peer reviewed and clinically relevant journal, the AJHNM can trace its origins back to publications issued by the Association as long ago as the 1930s. Issued quarterly, the AJHNM publishes material on all aspects of herbal medicine including philosophy, phytochemistry, pharmacology and the clinical application of medicinal plants.
- 1 September 2019
- Published by Elsevier in Advances in Integrative Medicine
- Vol. 6 (3) , 95-96
Natural products regulation – Getting the balance right. The case of arbutin
- 1 September 2019
- Published by Elsevier in Advances in Integrative Medicine
- Vol. 6 (3) , 95-96
Natural products regulation – Getting the balance right. The case of arbutin